Apple chipmaker TSMC has announced plans to produce highly advanced 1.6nm chips that could be destined for future generations of Apple silicon. TSMC yesterday unveiled a series of technologies, ...

Q2 2026 Management View CEO Richard Wallace highlighted that for 2025, KLA delivered 17% revenue growth to $12.745 billion, ...

TL;DR: TSMC plans to increase prices for its 5nm and 3nm process nodes by 5-10% and CoWoS advanced packaging by 15-20% due to high AI demand. These price hikes are expected in January 2025. The 3nm ...

Forbes contributors publish independent expert analyses and insights. Dave Altavilla is a Tech Analyst covering chips, compute and AI. In a joint announcement reflecting the growing importance of ...

LONDON--(BUSINESS WIRE)--Process Systems Enterprise Inc. (PSE), the Advanced Process Modeling (APM) company, today announced it signed a corporate agreement making its industry leading gPROMS equation ...

In the manufacturing world, the word “retrofit” many times is feared to mean “lost production.” In other words, plants—or at least parts of plants—must be shut down for equipment to be upgraded. And ...

In January 2025, while the global AI and semiconductor industries remained focused on advanced process nodes and high-performance GPUs, China's large-scale model DeepSeek-R1 emerged... As artificial ...

Hosting its third annual Intel Innovation event today, Intel Corp. took the opportunity to announce an array of new silicon platforms that it says will support artificial intelligence in every ...

The MVA platform is uniquely designed to incorporate multiple antigens into a single vaccine. This versatility allows GeoVax to develop vaccines targeting multiple aspects of a single pathogen or ...

Samsung said on Thursday that it has started mass production of chips using its 3-nanometer (nm) process node, its most advanced technology yet for contract chip production. The South Korean tech ...

Gaining an early understanding of every step in your manufacturing and analytical processes is essential to bringing gene and cell therapies successfully to market. That’s according to Melissa van Pel ...